Literature DB >> 8161380

Identification of serious illness in febrile adults.

E J Gallagher1, F Brooks, P Gennis.   

Abstract

To determine whether age and other readily obtainable clinical and laboratory variables could be used to predict illness severity in febrile adults, data were collected on 39 patients presenting to an emergency department (ED) with rectal temperature > or = 37.8 degrees C (100 degrees F). Serious illness was defined as (1) need for emergency surgery; (2) intubation; (3) hypotension requiring treatment; (4) bacteremia requiring antibiotics; or (5) death. Six variables were associated with serious illness in the univariate analysis. In a stepwise logistic regression model, only age (P < .0001) and leukocyte count (P < .002) were independently associated with serious illness. Optimal partitioning of these two variables showed that febrile adults younger than 50 years of age with leukocyte counts of less than 15 E9/L have a 5% incidence of serious illness (95% confidence interval [CI], 3% to 8%). In contrast, those who are > or = 50 years of age with leukocyte counts > or = 15 E9/L have a 36% incidence of serious illness (95% CI, 22% to 52%). Patients in this latter category should be carefully examined and considered for hospitalization before concluding that they may be safely discharged from the ED.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161380     DOI: 10.1016/0735-6757(94)90230-5

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  Identifying infected emergency department patients admitted to the hospital ward at risk of clinical deterioration and intensive care unit transfer.

Authors:  Maura Kennedy; Nina Joyce; Michael D Howell; J Lawrence Mottley; Nathan I Shapiro
Journal:  Acad Emerg Med       Date:  2010-10       Impact factor: 3.451

2.  Febrile adults presenting to the emergency department: outcomes and markers of serious illness.

Authors:  J C Knott; S-L Tan; A C Street; M Bailey; P Cameron
Journal:  Emerg Med J       Date:  2004-03       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.